Background and Aim: About one fifth of the deaths attributed to tobacco worldwide occur in India, where it is illegal for minors under 18 years of age to purchase or use tobacco products. To guide tobacco control efforts, we conducted a community-based study to estimate the prevalence of tobacco use among adolescents in the Indian state of Uttarakhand. Methods: We randomly selected 20 households in 30 clusters in the block of Gadarpur of the Udham Singh Nagar district. We interviewed adolescents between 13 and 15 years of age using semi-structured questionnaires between September and December 2005. We calculated prevalence and prevalence ratios using Epi-Info. Results: We recruited 600 adolescents (Median age: 14 years, 27% of females). 179 subjects (30%, 95% confidence interval (CI) = 26% 34%) reported having ever used tobacco (28%, 95% CI = 21 35 and 27%; 95% CI = 20 34 for smoking and smokeless form of tobacco use, respectively. Males were more likely to have ever used tobacco (prevalence ratio [PR]: 1.7, 95% CI = 1.2 2.3), 376 of the 595 adolescents (63%) from whom the information was available had a father using tobacco. This was associated with a higher prevalence of current tobacco use (PR: 3, 95%; CI = 2 4).
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Conclusion:
The high prevalence of tobacco use among adolescents is a cause of substantial concern. Legal restrictions on sale and use of tobacco products are ineffective. Innovative strategies involving parents and peers are needed to stop this developing epidemic.
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Application of SIR epidemiological model in determination of measles epidemics G. Babaee *, P. Ashkvari. Islamic Azad University, Karaj Brunch, Karaj, Iran Introduction: In the nineteenth century recurrent epidemics of cholera and influenza and decreasing cases of diseases in the later years caused that produce the question why communicable disease would suddenly produce epidemics and disappears then. Designing one model bases mathematical such as SIR model have been done for the question response the aim of research survey model on the measles in Iran and determination of outbreaks of measles at 1996 and determine necessary least vaccine covering for prediction of measles epidemics in the future. Methods and Materials: With collection of data from disease control center, the number of suffering to measles, age mean of measles and life expanses calculated and the number of suffering to measles, age mean of measles and life expanses calculated and the amount of R0 (Basic Reproduction Rate) resulted. Results: Calculating R0 amount at range 5.5 to 7.49 have been resulted that for the reason R0 amounts greater than one the measles epidemic has occurred in our country and least effective vaccine covering has been 81.8 86.65%. Discussion: Calculating R0 and necessary least vaccine covering for prediction measles epidemics determine that for epidemic control least vaccine covering, must more than 82.65%. Decreasing herd immunity and increasing measles age mean under conditions due to another epidemic in the 2005. Methods: A retrospective analysis of 145 patients with SBP was performed, including the general data, cause of disease, clinical manifestation, laboratory examination and prognosis. All cases were performed with blood routine test, blood clotting function and biochemical tests. 121 cases were performed with ascites routine tests and ascites cultures. All patients were given antibacterials of third generation cephalosporin and/or quinolones on the basis of routine supportive therapy. Results: Among these study the patients with cirrhosis were 130 (89.66%), including 77 cases (53.10%) with hepatitis B, 27 cases (18.62%) with hepatitis C, 9 cases (6%) with primary biliary cirrhosis, 12 cases (8%) with alcoholic cirrhosis, 5 cases (3%) with cryptogenic cirrhosis, 15 cases (10%) with severe hepatitis. In clinical manifestation, 35 cases (24.14%) with fever, 61 cases (42.06%) with abdominal pain, 76 cases (52.41%) with abdominal distension, 29 cases (20%) with diarrhea, 48 cases (33.10%) with hypourocrinia, 25 cases (17.24%) with abdominal rigidity, 65 cases (44.82%) with abdominal tenderness, 21 cases (14.48%) with abdominal rebound pain. In 37 cases (22.52%), peripheral white blood cell counts were >10 × 10 9 /L, 4 10×10 9 /L in 86 cases (59.31%), <4 × 10 9 /L in 22 cases (15.17%). 102 cases (70.35%) whose eutrophil percentage was >70%. 91 cases (62.75%) whose serum albumin level were <30 g/L. 94 cases (64.8%) whose INR were >1.5. In 86 cases (71.2%) whose ascites white cell counts were >250 × 10 6 /L, in 95 cases (78.5%) whose polymorphonuclear cell percentage was >25%, in 97 cases (85.16%) whose ascites albumin level were <30 g/L Ascites culture positive rate were 21.49% (26/121), among them gram stain negative (G ) bacteria were 17 cases (65.38%), gram stain positive (G + ) were 9 cases (34.61%). 83 cases with other common complications, among them 61% patients were died, 39% patients were survival. All patients with hepatorenal syndrome were died. In quinolones antibacterials group, 20 cases were survival (71%), in third generation cephalosporin antibacterials group, 29 cases were survival (78%), in combined antibacterials group, and 72 cases were survival (91%). Conclusion: Cirrhosis was the most common cause of SBP. The symptoms and signs of SBP were atypical. Abdominal Pain, abdominal distention and abdominal tenderness were common. Peripheral blood leucocyte counts were less increased, but most cases whose eutrophil percentage were >70%. 90% cases with hypoproteinemia and coagulation disorders. Acites white cell counts and polymorphonuclear cell percentage had high diagnostic value for SBP patients. Ascites culture positive rate were low. The main positive bacteria were gram stain negative (G ) bacteria. Hepatorenal syndrome was the most severe and fetal complication of SBP. Combined use of antibacterials increased the therapeutic effects and improves the prognosis of patients with SBP. The aqueous ethanolic plant leaves extract of Basella alba (100, 200 and 400 mg/kg bw) were administered to animals significantly inhibited hepatocarcinogenesis induced by N-nitrosodiethylamine (NDEA) and CCl 4 (promoter) in a dose dependent manner. Their effect on tumour incidence, levels of liver cancer markers and liver injury markers evaluated the anticarcinogenic activity of the extract. Animals treated with single injection of NDEA (200 mg/kg bw. ip) & CCL 4 (3 ml/kg bw/week. sc) for 6 weeks group showed 100% tumour incidence. The level of g-gamma glutamyl transpeptidase (GGT) in both serum and liver was found to be elevated in tumour bearing animals, while they were significantly reduced upon treatment with treated group. Serum levels of Aspartate aminotransaminase (SGOT) and alanine aminotransferase (SGPT), and Alkaline phosphatase (ALP), which are markers of liver injury, were elevated in groups treated with NDEA & CCL 4 . Administration of plant extract recuped back to near normal in a dose dependent manner. Animals treated with NDEA & CCL 4 group significantly elevated tissue levels of drug metabolizing enzymes such as glutathione S-transferase (GST) and Glutathione (GSH) and Glutathione peroxidase (Gpx). Upon treatment with extract significantly reduced these levels in a dose dependent manner. The level of lipid peroxidation (LPO) markedly increased in NDEA & CCL 4 treated groups, which was brought back to near normal by B. alba treatment. In contrast the activities/levels of the Superoxide dismutase (SOD) and Catalase status in the liver were decreased in NDEA & CCL 4 administered animals, which was recouped back to near normal upon treatment with B. alba extract. Histopathological studies of liver tissues showed a gradual development of normal architecture upon treatment with the extract and levels of marker enzymes indicated that the extract offered a good antioxidant and greater protection against chemical carcinogenesis induced hepatocarcinogenesis.
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